---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-126794"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2021-10-15T23:59:59+00:00"
generated_at: "2026-06-28T20:37:22.257331+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals raises ~$5.7M in registered direct offering led by largest shareholder

## Summary
- Offering of 3,323,616 shares at $1.715 per share; warrants for same number at same price, 5-year term.
- Gross proceeds ~$5.7M; net proceeds ~$5.4M after fees; expected close Oct 18, 2021.
- Proceeds will fund expansion of men's health platform and general corporate purposes.
- Katalyst Securities served as financial advisor; advisory fee and expenses $235,000 plus 130,000 warrants.
- Largest shareholder led the offering; warrants issued in private placement, unregistered.

## SEC filing metadata
- accession: 0001104659-21-126794
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2021-10-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465921126794/0001104659-21-126794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465921126794/tm2130098d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-126794
- JSON: https://secwatch.observer/filing/0001104659-21-126794.json
- Plain text: https://secwatch.observer/filing/0001104659-21-126794.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.